Drug Pipeline

VSA003 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Phase 3
2
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT07473843
Study of Zodasiran in Adolescent Participants With Homozygous Familial…		 date change Completion moved earlier: 2029-05 -> 2028-08
2026-05-29 NCT07037771
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial…		 Trial sites expanded: 35 -> 42 locations
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07037771 A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial… Homozygous Familial Hypercholesterolemia Recruiting
NCT06712771 A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of VSA003 in Chinese HoFH… Homozygous Familial Hypercholesterolemia (HoFH) Active, Not Recruiting
NCT07473843 Study of Zodasiran in Adolescent Participants With Homozygous Familial… Homozygous Familial Hypercholesterolemia Not Yet Recruiting
Sponsors Running VSA003 Trials
Arrowhead Pharmaceuticals (2) Visirna Therapeutics HK Limited (1)
Get alerts when VSA003 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free